Human LMP2/PSMB9 Antibody (792520)
R&D Systems | Catalog # MAB7709
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Validated by
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Thr21-Glu219
Accession # P28065
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human LMP2/PSMB9 Antibody (792520)
Detection of Human LMP2/PSMB9 by Western Blot.
Western blot shows lysates of HeLa human cervical epithelial carcinoma cell line treated (+) with 100 ng/mL Recombinant Human IFN-gamma (Catalog # 285-IF) for 24 hours. PVDF membrane was probed with 1 µg/mL of Mouse Anti-Human LMP2/PSMB9 Monoclonal Antibody (Catalog # MAB7709) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF007). A specific band was detected for LMP2/PSMB9 at approximately 22 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.LMP2/PSMB9 in HeLa Human Cell Line.
LMP2/PSMB9 was detected in immersion fixed HeLa human cervical epithelial carcinoma cells stimulated with Recombinant Human IFN-gamma (Catalog # 285-IF) for 24 hours using Mouse Anti-Human LMP2/PSMB9 Monoclonal Antibody (Catalog # MAB7709) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.Detection of LMP2/PSMB9 by Western Blot
Generation of hTAP-LMP transgenic mice.(A) Schematic map of the BAC clone RP11-10A19. (B) PCR genotyping of the founder mice. F2 and F14 were the two positive founder mice. “−”, tail DNA samples of WT littermates; “+”, plasmid DNA of the BAC clone RP11-10A19. (C) Relative mRNA expression of human TAP1, TAP2, PSMB8, and PSMB9 in splenocytes from WT or hTAP-LMP mice as analyzed by qRT-PCR and normalized to 18S rRNA levels. (D) Expression of human TAP1 (65 kDa), TAP2 (75 kDa), PSMB8 (23/28 kDa), and PSMB9 (22 kDa) in WT or hTAP-LMP mice was determined by western blotting; beta -actin (42 kDa) was used as an internal control. (E) FACS analysis for CD4 and CD8 expression of splenocytes from WT and hTAP-LMP mice (up), with the percentage of CD4+ T cells (below, left) and CD8+ T cells (below, right). PCR genotyping and western blotting were performed on individual mice, and the depicted results are representative of at least three independent experiments. Full-length PCR gels and Western blots are presented in Supplementary Figs S6 and S7, respectively. Results of the qRT-PCR and FACS analysis are representative of at least three independent experiments with n ≥ 3. Data represent the mean ± SD. ns, not significant. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/27634283), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of LMP2/PSMB9 by Western Blot
Generation of hTAP-LMP transgenic mice.(A) Schematic map of the BAC clone RP11-10A19. (B) PCR genotyping of the founder mice. F2 and F14 were the two positive founder mice. “−”, tail DNA samples of WT littermates; “+”, plasmid DNA of the BAC clone RP11-10A19. (C) Relative mRNA expression of human TAP1, TAP2, PSMB8, and PSMB9 in splenocytes from WT or hTAP-LMP mice as analyzed by qRT-PCR and normalized to 18S rRNA levels. (D) Expression of human TAP1 (65 kDa), TAP2 (75 kDa), PSMB8 (23/28 kDa), and PSMB9 (22 kDa) in WT or hTAP-LMP mice was determined by western blotting; beta -actin (42 kDa) was used as an internal control. (E) FACS analysis for CD4 and CD8 expression of splenocytes from WT and hTAP-LMP mice (up), with the percentage of CD4+ T cells (below, left) and CD8+ T cells (below, right). PCR genotyping and western blotting were performed on individual mice, and the depicted results are representative of at least three independent experiments. Full-length PCR gels and Western blots are presented in Supplementary Figs S6 and S7, respectively. Results of the qRT-PCR and FACS analysis are representative of at least three independent experiments with n ≥ 3. Data represent the mean ± SD. ns, not significant. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/27634283), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human LMP2/PSMB9 Antibody (792520)
Immunocytochemistry
Sample: Immersion fixed HeLa human cervical epithelial carcinoma cells stimulated with Recombinant Human IFN‑ gamma (Catalog # 285-IF) for 24 hours
Western Blot
Sample: HeLa human cervical epithelial carcinoma cell line treated with Recombinant Human IFN‑ gamma (Catalog # 285-IF)
Formulation, Preparation, and Storage
Purification
Reconstitution
Sterile PBS to a final concentration of 0.5 mg/mL. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: LMP2/PSMB9
Long Name
Alternate Names
Gene Symbol
UniProt
Additional LMP2/PSMB9 Products
Product Documents for Human LMP2/PSMB9 Antibody (792520)
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human LMP2/PSMB9 Antibody (792520)
For research use only
Related Research Areas
Citations for Human LMP2/PSMB9 Antibody (792520)
Customer Reviews for Human LMP2/PSMB9 Antibody (792520)
There are currently no reviews for this product. Be the first to review Human LMP2/PSMB9 Antibody (792520) and earn rewards!
Have you used Human LMP2/PSMB9 Antibody (792520)?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 for a review with an image
$10/€7/£6/$10CAN/¥1110 for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- ClariTSA™ Fluorophore Kits
- Detection & Visualization of Antibody Binding
- ICC Cell Smear Protocol for Suspension Cells
- ICC Immunocytochemistry Protocol Videos
- ICC for Adherent Cells
- Immunocytochemistry (ICC) Protocol
- Immunocytochemistry Troubleshooting
- Immunofluorescence of Organoids Embedded in Cultrex Basement Membrane Extract
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Fluorescent ICC Staining of Cell Smears - Graphic
- Protocol for the Fluorescent ICC Staining of Cultured Cells on Coverslips - Graphic
- Protocol for the Preparation and Fluorescent ICC Staining of Cells on Coverslips
- Protocol for the Preparation and Fluorescent ICC Staining of Non-adherent Cells
- Protocol for the Preparation and Fluorescent ICC Staining of Stem Cells on Coverslips
- Protocol for the Preparation of a Cell Smear for Non-adherent Cell ICC - Graphic
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars